Pretreatment lymphocytopenia is an adverse prognostic biomarker in advanced‐stage ovarian cancer

Abstract The aim of this study was to investigate the prognostic significance of lymphocytopenia in advanced‐stage ovarian cancer. We retrospectively reviewed 506 patients with advanced‐stage ovarian cancer at Yonsei Cancer Hospital. This study included two cohorts of patients: a neoadjuvant chemoth...

Full description

Bibliographic Details

Published in:	Cancer Medicine
Main Authors:	Yong Jae Lee, Young Shin Chung, Jung‐Yun Lee, Eun Ji Nam, Sang Wun Kim, Sunghoon Kim, Young Tae Kim
Format:	Article
Language:	English
Published:	Wiley 2019-02-01
Subjects:	immune suppression lymphocytopenia ovarian cancer prognosis
Online Access:	https://doi.org/10.1002/cam4.1956